Repeated Measures of Modified Rankin Scale Scores to Assess Functional Recovery From Stroke: AFFINITY Study Findings.
Alexander ChyeMaree L HackettGraeme J HankeyErik LundströmOsvaldo P AlmeidaJohn Henry GommansMartin S DennisStephen JanGillian Elizabeth MeadAndrew Hugh FordChristopher Etherton BeerLeon FlickerCandice DelcourtLaurent BillotCraig S AndersonKatharina Stibrant SunnerhagenQilong YiSeverine BompointThang Huy NguyenThomas LungPublished in: Journal of the American Heart Association (2022)
Background Function after acute stroke using the modified Rankin Scale (mRS) is usually assessed at a point in time. The analytical implications of serial mRS measurements to evaluate functional recovery over time is not completely understood. We compare repeated-measures and single-measure analyses of the mRS from a randomized clinical trial. Methods and Results Serial mRS data from AFFINITY (Assessment of Fluoxetine in Stroke Recovery), a double-blind placebo randomized clinical trial of fluoxetine following stroke (n=1280) were analyzed to identify demographic and clinical associations with functional recovery (reduction in mRS) over 12 months. Associations were identified using single-measure (day 365) and repeated-measures (days 28, 90, 180, and 365) partial proportional odds logistic regression. Ninety-five percent of participants experienced a reduction in mRS after 12 months. Functional recovery was associated with age at stroke <70 years; no prestroke history of diabetes, coronary heart disease, or ischemic stroke; prestroke history of depression, a relationship partner, living with others, independence, or paid employment; no fluoxetine intervention; ischemic stroke (compared with hemorrhagic); stroke treatment in Vietnam (compared with Australia or New Zealand); longer time since current stroke; and lower baseline National Institutes of Health Stroke Scale & Patient Health Questionnaire-9 scores. Direction of associations was largely concordant between single-measure and repeated-measures models. Association strength and variance was generally smaller in the repeated-measures model compared with the single-measure model. Conclusions Repeated-measures may improve trial precision in identifying trial associations and effects. Further repeated-measures stroke analyses are required to prove methodological value. Registration URL: http://www.anzctr.org.au; Unique identifier: ACTRN12611000774921.
Keyphrases
- atrial fibrillation
- healthcare
- public health
- mental health
- type diabetes
- randomized controlled trial
- cerebral ischemia
- clinical trial
- study protocol
- depressive symptoms
- mass spectrometry
- phase iii
- brain injury
- case report
- mental illness
- sensitive detection
- quantum dots
- health information
- insulin resistance
- physical activity
- deep learning
- blood brain barrier
- human immunodeficiency virus
- smoking cessation
- gold nanoparticles
- artificial intelligence
- antiretroviral therapy
- sleep quality